Skip to content

Understanding Biopharmaceuticals: Manufacturing and Regulatory Issues
Stock Photo: Cover May Be Different

Understanding Biopharmaceuticals: Manufacturing and Regulatory Issues Hardcover - 1999

by June Grindley (Editor); Jill Ogden (Editor)


From the publisher

Understanding Biopharmaceuticals: Manufacturing and Regulatory Issues offers exceptionally broad coverage of the biopharmaceutical industry from the commercial, regulatory, clinical, and manufacturing points of view. It provides a detailed analysis of the market for biopharmaceuticals and reviews the activities required to take a biopharmaceutical product from the laboratory to the marketplace. Industry experts discuss the status of the biopharmaceutical market in terms of approved recombinant proteins, vaccines, and monoclonal antibodies. They also explore the impact that the human genome sequencing project and associated activities will have on the market and the prospects for "biogeneric" and second-generation versions of certain drugs. Numerous specific examples and case histories support the text.

First line

This chapter serves to introduce the various chapters of the book and to give our rationale for writing it at this time.

Details

  • Title Understanding Biopharmaceuticals: Manufacturing and Regulatory Issues
  • Author June Grindley (Editor); Jill Ogden (Editor)
  • Binding Hardcover
  • Edition First
  • Pages 342
  • Volumes 1
  • Language ENG
  • Publisher CRC Press
  • Date December 31, 1999
  • Illustrated Yes
  • ISBN 9781574910834 / 1574910833
  • Weight 1.53 lbs (0.69 kg)
  • Dimensions 9.46 x 6.04 x 1.04 in (24.03 x 15.34 x 2.64 cm)
  • Library of Congress subjects Pharmaceutical biotechnology, Pharmaceutical biotechnology industry - Law
  • Library of Congress Catalog Number 99043041
  • Dewey Decimal Code 615.19